Related Experiment Video

Updated: Aug 14, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

Management of bleeding disorders in children

Catherine S Manno1

  • 1The Children's Hospital of Philadelphia, 34th & Civic Center Blvd., Rm. 9518 Main Bldg., Philadelphia, PA 19104, USA. manno@email.chop.edu

Hematology. American Society of Hematology. Education Program
|November 24, 2005
PubMed

Insights

Pediatric bleeding disorders like neonatal alloimmune thrombocytopenia, hemophilia, and immune-mediated thrombocytopenic purpura require specialized care. Management strategies are evolving, focusing on prophylaxis for hemophilia and careful observation for ITP in children.

Area of Science:

  • Pediatric Hematology
  • Hemostasis and Thrombosis
  • Immunology

Background:

  • Pediatric hemostasis differs from adult physiology.
  • Bleeding disorders in children have unique natural courses.
  • Neonatal alloimmune thrombocytopenia (NAIT), hemophilia, and immune-mediated thrombocytopenic purpura (ITP) are key pediatric hematologic concerns.

Purpose of the Study:

  • To review the diagnosis and management of three critical pediatric bleeding disorders.
  • To outline current therapeutic approaches for NAIT, hemophilia, and ITP.
  • To highlight the distinct aspects of pediatric hemostasis and disease progression.

Main Methods:

  • Review of current literature and management strategies for NAIT, hemophilia, and ITP.
  • Discussion of pediatric hemostatic physiology.
  • Analysis of treatment outcomes and side effects.

Main Results:

  • Neonatal immune thrombocytopenia due to NAIT is a significant cause of infant morbidity and mortality.
  • Prophylaxis has become the standard for hemophilia management, preventing arthropathy.
  • Inhibitor development in hemophilia necessitates understanding of bypassing agents and immune tolerance.
  • ITP management involves various treatments, but observation is a viable option due to side effects of interventions.

Conclusions:

  • Effective management of pediatric bleeding disorders demands specialized knowledge of pediatric hemostasis.
  • Shifting treatment paradigms, such as prophylaxis in hemophilia, improve patient outcomes.
  • Careful consideration of treatment risks versus benefits is crucial, particularly in ITP management.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...